Condition
Pertuzumab
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Chest Wall Breast Radiation With Or Without Lymph Node Region Radiationfor All Of The Enrolled Patients
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Chest Wall Breast Radiation With Or Without Lymph Node Region Radiationfor All Of The Enrolled Patients1
Active Sponsors
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Top Investigators
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Related Conditions
- Radiotherapy Complications1
- Parp Inhibitor1
- Chemotherapeutic Toxicity1
- Cdk46 Inhibitor1
- Trastuzumab1